Complicaciones hemorrágicas en cirugía dermatológica: ¿es necesario suspender la terapia antiagregante y/o anticoagulante?

• Bosch Amate, X. ^[1] ; Morgado Carrasco, D. ^[1]
  1. [1] Hospital Clinic Barcelona

     Hospital Clinic Barcelona

     Barcelona, España

     
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 36, Nº. 3 (MARZO), 2021, págs. 137-139
• Idioma: español
• DOI: 10.1016/j.piel.2020.12.001
• Títulos paralelos:
  • Hemorrhagic complications in dermatological surgery: Is it necessary to suspend antiplatelet and/or anticoagulant therapy?
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Alam M, Ibrahim O, Nodzenski M, et al. Adverse events associated with Mohs micrographic surgery: multicenter prospective cohort study of 20,821...
  • Bordeaux JS, Martires KJ, Goldberg D, Pattee SF, Fu P, Maloney ME. Prospective evaluation of dermatologic surgery complications including...
  • O'Neill J, Taheri A, Solomon J, Pearce D. Postoperative hemorrhage risk after outpatient dermatologic surgery procedures. Dermatol Surg....
  • Taylor O, Carr C, Greif C, et al. Postoperative bleeding complications associated with blood thinning agents during Mohs micrographic surgery:...
  • Cabezas-Calderon V, Bassas Freixas P, García-Patos Briones V. Anticoagulantes orales directos en cirugía dermatológica. Actas Dermosifiliogr....
  • Plovanich M, Mostaghimi A. Novel oral anticoagulants: what dermatologists need to know. J Am Acad Dermatol. 2015;72: 535–540.
  • Robinson A, McCarty D, Douglas J. Novel oral anticoagulants for acute coronary syndrome. Ther Adv Cardiovasc Dis. 2017;11: 4–11.
  • Franco Moreno AI, Martín Díaz RM, García Navarro MJ. Direct oral anticoagulants: an update. Med Clin (Barc). 2018;151: 198–206.
  • Thomas TF, Ganetsky V, Spinler SA. Rivaroxaban: an oral factor Xa inhibitor. Clin Ther. 2013;35:4–27.
  • Byon W, Garonzik S, Boyd RA, Frost CE. Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet. 2019;58:1265–1279.
  • Poulakos M, Walker JN, Baig U, David T. Edoxaban: a direct oral anticoagulant. Am J Health-Syst Pharm. 2017;74:117–129.
  • Antonijevic NM, Zivkovic ID, Jovanovic LM, et al. Dabigatran - metabolism, pharmacologic properties and drug interactions. Curr Drug Metab....
  • Koenen W, Kunte C, Hartmann D, et al. Prospective multicentre cohort study on 9154 surgical procedures to assess the risk of postoperative...